Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pfizer (GB:0Q1N)
LSE:0Q1N
Pfizer (0Q1N) Share Price & Analysis
30 Followers
0Q1N Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$25.21 - $39.62
Previous Close$25.4
Volume74.95K
Average Volume (3M)350.99K
Market Cap
$148.62B
Enterprise Value$203.36B
Total Cash (Recent Filing)$12.69B
Total Debt (Recent Filing)$72.35B
Price to Earnings (P/E)67.6
Beta0.50
Next Earnings
May 01, 2024EPS Estimate
$0.53Next Dividend Ex-Date
May 09, 2024Dividend Yield6.53%
Share Statistics
EPS (TTM)0.36
Shares Outstanding5,646,778,425
10 Day Avg. Volume1,642
30 Day Avg. Volume350,990
Standard Deviation0.06
R-Squared0.21
Alpha-0.00690
Financial Highlights & Ratios
Price to Book (P/B)-3.27
Price to Sales (P/S)2.96
Price to Cash Flow (P/CF)6.80
P/FCF Ratio7.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.48
Enterprise Value/Gross Profit6.06
Enterprise Value/Ebitda39.82
Forecast
1Y Price Target
$31.57Price Target Upside24.29% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Pfizer News
Bulls Say, Bears Say
Bulls Say
Pipeline AdvancementPfizer's next-generation pneumococcal vaccine aims to cover more serotypes than Prevnar20, using new conjugation chemistry, showcasing innovation in its vaccine development.
Product SalesPaxlovid is positioned for upside with strong results expected and potential to exceed future guidance based on current trends.
Strategic GrowthThe integration of Seagen is expected to drive significant growth, with Pfizer projecting $10 billion in sales by 2030, indicating a robust growth strategy.
Bears Say
Drug DevelopmentA setback in the development of an oral GLP-1 drug for weight loss could delay Pfizer's entry into the competitive market for weight-loss therapies.
Financial HealthPfizer's balance sheet has weakened, with a significant increase in the debt/equity ratio and total debt nearly doubling from the previous year.
Financial PerformanceProducts such as Nurtec, Prevnar, and Ibrance may disappoint with sales missing consensus estimates.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.26% Insiders
22.07% Mutual Funds
22.98% Other Institutional Investors
54.69% Public Companies and
Individual Investors
0Q1N FAQ
What was Pfizer’s price range in the past 12 months?
Pfizer lowest share price was $25.21 and its highest was $39.62 in the past 12 months.
What is Pfizer’s market cap?
Currently, no data Available
When is Pfizer’s upcoming earnings report date?
Pfizer’s upcoming earnings report date is May 01, 2024 which is in 4 days.
How were Pfizer’s earnings last quarter?
Pfizer released its earnings results on Jan 30, 2024. The company reported $0.1 earnings per share for the quarter, beating the consensus estimate of -$0.158 by $0.258.
Is Pfizer overvalued?
According to Wall Street analysts Pfizer’s price is currently Undervalued.
Does Pfizer pay dividends?
Pfizer pays a Quarterly dividend of $0.42 which represents an annual dividend yield of 6.53%. See more information on Pfizer dividends here
What is Pfizer’s EPS estimate?
Pfizer’s EPS estimate is $0.53.
How many shares outstanding does Pfizer have?
Pfizer has 5,646,778,300 shares outstanding.
What happened to Pfizer’s price movement after its last earnings report?
Pfizer reported an EPS of $0.1 in its last earnings report, beating expectations of -$0.158. Following the earnings report the stock price went down -0.73%.
Which hedge fund is a major shareholder of Pfizer?
Among the largest hedge funds holding Pfizer’s share is Diamond Hill Capital Management Inc. It holds Pfizer’s shares valued at 340M.
---
Pfizer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$31.57 (24.29% Upside)
$31.57 (24.29% Upside)
Blogger Sentiment
Bullish
GB:0Q1N Sentiment 77%
Sector Average 70%
Sector Average 70%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.86%
12-Months-Change
Fundamentals
Return on Equity
2.31%
Trailing 12-Months
Asset Growth
14.86%
Trailing 12-Months
Company Description
Pfizer
Pfizer Inc. develops, manufactures and sells healthcare products, including innovative medicines and vaccines. Its key focus areas include oncology, inflammation & immunology, rare disease, vaccines and internal medicine. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
---
0Q1N Company Deck
---
0Q1N Earnings Call
Q4 2024
0:00 / 0:00
---
0Q1N Revenue Breakdown
52.29% Primary Care
25.59% Specialty Care
19.88% Oncology
2.24% BUSINESS INNOVATION
---
0Q1N Stock 12 Months Forecast
Average Price Target
$31.57
▲(24.29% Upside)
Technical Analysis
Best Analysts Covering 0Q1N
1 Year
1 Year Success Rate
25/34 ratings generated profit
1 Year Average Return
+5.34%
initiated a buy rating 2 months ago
Copying Vamil Divan's trades and holding each position for 1 Year would result in 73.53% of your transactions generating a profit, with an average return of +5.34% per trade.
---